The role of advanced brain magnetic resonance imaging techniques in small cell lung cancer

Not Applicable

Completed

• Conditions: Small cell lung cancer; Cancer; Malignant neoplasm of bronchus and lung

• Registration Number: ISRCTN44860775
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-28
• Study Completion: 2011-11-09
• Last Update Posted: 15 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

1. Ability to give written informed consent
2. Aged greater than 18 years, either sex
3. Histologically or cytologically confirmed small cell lung cancer
4. No previous malignancy
5. No prior chemotherapy
6. Satisfactory renal function (ethylenediaminetetraacetic acid [EDTA] clearance greater than 60 ml/min)
7. Satisfactory World Health Organization (WHO) performance status 0, 1 or 2

Exclusion Criteria

1. Prior chemotherapy or radiotherapy to primary tumour
2. Central nervous system (CNS) disease
3. Previous or coexistent malignancies
4. Pregnancy or breastfeeding
5. Any other medical condition making participation in a clinical trial undesirable

Study & Design

• Study Type: Interventional
• Study Design: Not specified